Functional Medicine Research Center
Gig Harbor, Washington, 98332, United States
NCT Number: NCT01671254
The purpose of this 8-week intervention trial is to investigate the effect of a dietary supplement (containing citrus bioflavonoids and vitamin E) plus fish oil supplementation in healthy hyperlipidemic subjects
Looking for future studies?
Notify Me18 year–72 year
All sexes
Interventional
Not applicable
Gig Harbor, Washington, 98332, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline, 8 weeks
Change in LDL cholesterol level at the end of 8 weeks
Time frame: Baseline, 8 weeks
Change in triglyceride level at the end of 8 weeks.
Time frame: Baseline, 8 weeks
Change in oxidized LDL level at the end of 8 weeks.
Time frame: Baseline, 8 weeks
Change in total cholesterol level at the end of 8 weeks.
Time frame: Baseline, 8 weeks
Change in HDL cholesterol level at the end of 8 weeks.
MetaProteomics LLC
Industry
A Double-blind, Placebo-controlled Trial of a Dietary Supplement Containing Citrus Bioflavonoids and Vitamin E at 2 Doses in Conjunction With Fish Oil Supplementation in Hyperlipidemic Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07710898
Diabete Mellitus, Diabetes Mellitus
Lahore, Pakistan
View Trial DetailsNCT07696559
Dyslipidemias, Hyperlipidemia
Lahore, Pakistan
View Trial DetailsNCT00001154
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia
Bethesda, Maryland, United States
View Trial DetailsNCT01212159
Dyslipidemias, Hyperlipidemia
Philadelphia, Pennsylvania, United States
View Trial Details